Targeting histone deacetylase and NFκB signaling as a novel therapy for Mucoepidermoid Carcinomas.

about

Targeting histone deacetylase and NFκB signaling as a novel therapy for Mucoepidermoid Carcinomas.

Item

http://www.wikidata.org/entity/Q48120446

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Targeting histone deacetylase ...... for Mucoepidermoid Carcinomas.

@en

Targeting histone deacetylase ...... for Mucoepidermoid Carcinomas.

@nl

type

Item

label

Targeting histone deacetylase ...... for Mucoepidermoid Carcinomas.

@en

Targeting histone deacetylase ...... for Mucoepidermoid Carcinomas.

@nl

prefLabel

Targeting histone deacetylase ...... for Mucoepidermoid Carcinomas.

@en

Targeting histone deacetylase ...... for Mucoepidermoid Carcinomas.

@nl

P1476

Targeting histone deacetylase ...... for Mucoepidermoid Carcinomas

@en

P2093

Cristiane H Squarize

http://www.w3.org/2001/XMLSchema#string

Jacques E Nör

http://www.w3.org/2001/XMLSchema#string

Kristy A Warner

http://www.w3.org/2001/XMLSchema#string

Luciana O Almeida

http://www.w3.org/2001/XMLSchema#string

Manoela D Martins

http://www.w3.org/2001/XMLSchema#string

Marco A T Martins

http://www.w3.org/2001/XMLSchema#string

P2860

Evolutionary dynamics of cancer in response to targeted combination therapy

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.

Characterization of clonogenic multiple myeloma cells

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Molecular signatures of proliferation and quiescence in hematopoietic stem cells

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

DNA methyltransferase Dnmt1 associates with histone deacetylase activity

Identification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of action

Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer

P2888

s41598-018-20345-w

P304

2065

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-20345-W

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vivian Petersen Wagner

Rogerio M Castilho

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29391537

http://www.w3.org/2001/XMLSchema#string

P932

5794736

http://www.w3.org/2001/XMLSchema#string